| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |